GLP-1 injectable medications, such as semaglutide (Wegovy) and tirzepatide (Zepbound), are showing powerful results in weight management
For example, semaglutide typically starts at a low dose (0.25 mg weekly) and increases to a maintenance dose (2.4 mg weekly for weight loss) over 16 to 20 weeks
When you understand the pros and cons, you can use that knowledge to build a benefits program that works best for your people. Editors Note: Additional Content For more information and resources related to this article, see the pages below, which offer quick access to all WorldatWork content on these topics: #1 Total Rewards & Comp Newsletter Subscribe to Workspan Weekly and always get the latest news on compensation and Total Rewards delivered directly to you
however, due to the theoretical reproductive effects (discussed below), some guidelines suggest discontinuing GLP-1 RAs in men actively attempting fertility until more safety data are available
Cremonini E, Daveri E, Mastaloudis A, Oteiza PI
Picha, K
